Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan

BACKGROUND: Lung transplant (LTx) recipients are at higher risk of infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). There is an increasing demand for additional analysis regarding the efficacy and safety of after the initial series of mRNA SARS-CoV-2 vaccines in Japanese...

Descripción completa

Detalles Bibliográficos
Autores principales: Ui, Masahiro, Hirama, Takashi, Akiba, Miki, Honda, Masako, Kikuchi, Toshiaki, Okada, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250153/
https://www.ncbi.nlm.nih.gov/pubmed/37328349
http://dx.doi.org/10.1016/j.vaccine.2023.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250153/
https://www.ncbi.nlm.nih.gov/pubmed/37328349
http://dx.doi.org/10.1016/j.vaccine.2023.06.011

Ejemplares similares